Trials

University Hospitals Birmingham NHS Foundation Trust is a regional and national centre for specialist clinical services.

It is home to some of the country’s leading clinical research institutions, and is dedicated to developing and implementing groundbreaking treatments, technologies and techniques.

  • A multi centre double blind double dummy randomised positive controlled study comparing the efficacy and safety of Lacosamide (200 to 600mg/day) to controlled release Carbamazepine (400 to 1200mg/day) used as Monotherapy in subjects (=16 years) newly or recently diagnosed with Epilepsy and experiencing partial onset or generalised Tonic Clonic Seizures

    View Trial
  • Studies on regulation of thyroid cell growth and function

    View Trial
  • Does altering the activity of receptors for the active metabolite of vitamin A (all-trans retinoic acid) allow human adult blood cells to expand ex vivo?

    View Trial
  • CAVA

    Cancer and Venous Access (CAVA) – A randomised controlled trial with associated qualitative research of venous access devices for the delivery of long-term chemotherapy

    View Trial
  • Cogwatch

    Cognitive Rehabilitation of Apraxia and Action Disorganisation Syndrome

    View Trial
  • The ACQUATIK Study

    Acute Care QUAliTy in chronic Kidney Disease

    View Trial
  • RAPTOR

    A Long-Term Open-Label Safety and Superior Effectiveness Study of Cysteamine Bitartrate Delayedrelease Capsules (RP103) in Patients with Cystinosis

    View Trial
  • Dissecting mechanisms of regulation of gene expression in human leukaemia.

    View Trial
  • Sage and Thyme Communication Skills Training

    View Trial
  • The UK TAVI Trial V1.0

    The United Kingdom Transcatheter Aortic Valve Implantation (UK TAVI) Trial. A multi-centre randomised controlled trial to assess the clinical effectiveness and costutility of TAVI compared with conventional surgical aortic valve replacement in patients with severe symptomatic aortic stenosis at intermediate or high operative risk

    View Trial